Literature DB >> 17932505

Pseudoexfoliation syndrome prevalence in Greek patients with cataract and its association to glaucoma and coronary artery disease.

G K Andrikopoulos1, E K Mela, C D Georgakopoulos, G E Papadopoulos, A N Damelou, D K Alexopoulos, S P Gartaganis.   

Abstract

PURPOSE: To investigate the prevalence of glaucoma and coronary artery disease (CAD) in patients with cataract and pseudoexfoliation (PEX) syndrome.
METHODS: Cross-sectional study of 2140 consecutive patients with cataract admitted at the University Hospital of Patras, Greece, for cataract surgery. Only patients with senile cataract were included in this study. All patients underwent a complete ophthalmological examination that included slit-lamp evaluation with dilated pupil for PEX material in the anterior segment, intraocular pressure (IOP) measurements, and optic disc cup examination. They also underwent an evaluation for CAD by a cardiologist. CAD was considered present if a patient had a history of myocardial infarction, or ischaemia, or abnormal coronary angiography. The patients were classified into two groups: the PEX and the non-PEX group.
RESULTS: One thousand and eighty-eight (50.8%) patients were men and 1052 (49.2%) were women. The overall prevalence of PEX syndrome was found to be 27.9% and it was found to increase with progressing age. Bilateral PEX was more frequent than unilateral PEX, with the percentage of bilateral PEX raising with progressing age. A total of 132 patients (22.1%) in the PEX group exhibited glaucoma, while in the non-PEX group only 2.5% suffered glaucoma. PEX was also found to be positively associated with the risk for CAD among subjects 50 years or older. No association between CAD and glaucoma was found.
CONCLUSIONS: PEX syndrome constitutes a major glaucoma risk factor and a CAD risk factor. Patients with PEX should be informed and examined frequently as the risk is present throughout.

Entities:  

Mesh:

Year:  2007        PMID: 17932505     DOI: 10.1038/sj.eye.6702992

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  32 in total

1.  Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome.

Authors:  K Türkyılmaz; V Öner; A Kırbas; M S Sevim; B Sekeryapan; G Özgür; M Durmus
Journal:  Eye (Lond)       Date:  2013-05-10       Impact factor: 3.775

2.  Pseudoexfoliation syndrome and coronary artery ectasia.

Authors:  M O Akdemir; M R Sayin; M Armut; I Akpinar; S H Ugurbas
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775

3.  Assessment of myocardial ischaemia using tissue Doppler imaging in pseudoexfoliation syndrome.

Authors:  N Demir; T Ulus; O E Yucel; E T Kumral; E Singar; H I Tanboga
Journal:  Eye (Lond)       Date:  2011-06-24       Impact factor: 3.775

4.  Transmission electron microscopy study of undescribed material at the anterior lens capsule in exfoliation syndrome.

Authors:  Konstantina N Sorkou; Maria-Eleni Manthou; Konstantinos T Tsaousis; Periklis Brazitikos; Ioannis T Tsinopoulos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-07       Impact factor: 3.117

5.  Association of ocular pseudoexfoliation syndrome with ischaemic heart disease, arterial hypertension and diabetes mellitus.

Authors:  Martynas Spečkauskas; Abdonas Tamošiūnas; Vytautas Jašinskas
Journal:  Acta Ophthalmol       Date:  2012-05-02       Impact factor: 3.761

6.  Immunohistochemical analysis of microsomal glutathione S-transferase 1 and clusterin expression in lens epithelial cells of patients with pseudoexfoliation syndrome.

Authors:  Joanna Stafiej; Marta Hałas-Wiśniewska; Magdalena Izdebska; Maciej Gagat; Dariusz Grzanka; Alina Grzanka; Grażyna Malukiewicz
Journal:  Exp Ther Med       Date:  2017-01-24       Impact factor: 2.447

7.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

8.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01

Review 9.  Pseudoexfoliation syndrome and cardiovascular diseases.

Authors:  Georgios K Andrikopoulos; Dimitrios K Alexopoulos; Sotirios P Gartaganis
Journal:  World J Cardiol       Date:  2014-08-26

Review 10.  Ocular Pseudoexfoliation Syndrome Linkage to Cardiovascular Disease.

Authors:  Juan A Siordia; Jimena Franco; Todd R Golden; Bilal Dar
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.